BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38257071)

  • 1. Omega-3 Fatty Acids and Markers of Thrombosis in Patients with Atrial Fibrillation.
    Reiner MF; Bertschi DA; Werlen L; Wiencierz A; Aeschbacher S; Lee P; Rodondi N; Moutzouri E; Bonati L; Reichlin T; Moschovitis G; Rutishauser J; Kühne M; Osswald S; Conen D; Beer JH
    Nutrients; 2024 Jan; 16(2):. PubMed ID: 38257071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Omega-3 Fatty Acid Eicosapentaenoic Acid (EPA) Correlates Inversely with Ischemic Brain Infarcts in Patients with Atrial Fibrillation.
    Reiner MF; Baumgartner P; Wiencierz A; Coslovsky M; Bonetti NR; Filipovic MG; Montrasio G; Aeschbacher S; Rodondi N; Baretella O; Kühne M; Moschovitis G; Meyre P; Bonati LH; Lüscher TF; Camici GG; Osswald S; Conen D; Beer JH
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33671288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omega-3 Fatty Acids and Heart Rhythm, Rate, and Variability in Atrial Fibrillation.
    Baumgartner P; Reiner MF; Wiencierz A; Coslovsky M; Bonetti NR; Filipovic MG; Aeschbacher S; Kühne M; Zuern CS; Rodondi N; Oberle J; Moschovitis G; Lüscher TF; Camici GG; Osswald S; Conen D; Beer JH;
    J Am Heart Assoc; 2023 Jun; 12(11):e027646. PubMed ID: 37259986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 Fatty Acid Biomarkers and Incident Atrial Fibrillation.
    Qian F; Tintle N; Jensen PN; Lemaitre RN; Imamura F; Feldreich TR; Nomura SO; Guan W; Laguzzi F; Kim E; Virtanen JK; Steur M; Bork CS; Hirakawa Y; O'Donoghue ML; Sala-Vila A; Ardisson Korat AV; Sun Q; Rimm EB; Psaty BM; Heckbert SR; Forouhi NG; Wareham NJ; Marklund M; Risérus U; Lind L; Ärnlöv J; Garg P; Tsai MY; Pankow J; Misialek JR; Gigante B; Leander K; Pester JA; Albert CM; Kavousi M; Ikram A; Voortman T; Schmidt EB; Ninomiya T; Morrow DA; Bayés-Genís A; O'Keefe JH; Ong KL; Wu JHY; Mozaffarian D; Harris WS; Siscovick DS;
    J Am Coll Cardiol; 2023 Jul; 82(4):336-349. PubMed ID: 37468189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary ω-3 fatty acids and the incidence of atrial fibrillation in the Million Veteran Program.
    Guardino ET; Li Y; Nguyen XM; Wilson PWF; Gaziano JM; Cho K; Benjamin EJ; Djoussé L
    Am J Clin Nutr; 2023 Aug; 118(2):406-411. PubMed ID: 37353210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review.
    Balk EM; Adams GP; Langberg V; Halladay C; Chung M; Lin L; Robertson S; Yip A; Steele D; Smith BT; Lau J; Lichtenstein AH; Trikalinos TA
    Evid Rep Technol Assess (Full Rep); 2016 Aug; (223):1-1252. PubMed ID: 30307737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial.
    Myhre PL; Kalstad AA; Tveit SH; Laake K; Schmidt EB; Smith P; Nilsen DWT; Tveit A; Solheim S; Arnesen H; Seljeflot I
    J Intern Med; 2022 May; 291(5):637-647. PubMed ID: 34982486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Omega-3 Fatty Acid Levels and Risk for Incident Major Bleeding Events and Atrial Fibrillation: MESA.
    Kapoor K; Alfaddagh A; Al Rifai M; Bhatt DL; Budoff MJ; Nasir K; Miller M; Welty FK; McEvoy JW; Dardari Z; Shapiro MD; Blumenthal RS; Tsai MY; Blaha MJ
    J Am Heart Assoc; 2021 Jun; 10(11):e021431. PubMed ID: 34041918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 polyunsaturated fatty acid biomarkers and risk of type 2 diabetes, cardiovascular disease, cancer, and mortality.
    Jiang H; Wang L; Wang D; Yan N; Li C; Wu M; Wang F; Mi B; Chen F; Jia W; Liu X; Lv J; Liu Y; Lin J; Ma L
    Clin Nutr; 2022 Aug; 41(8):1798-1807. PubMed ID: 35830775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation: A Randomized Clinical Trial.
    Albert CM; Cook NR; Pester J; Moorthy MV; Ridge C; Danik JS; Gencer B; Siddiqi HK; Ng C; Gibson H; Mora S; Buring JE; Manson JE
    JAMA; 2021 Mar; 325(11):1061-1073. PubMed ID: 33724323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipose tissue n-3 fatty acids and metabolic syndrome.
    Cespedes E; Baylin A; Campos H
    Eur J Clin Nutr; 2015 Jan; 69(1):114-20. PubMed ID: 25097001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compartmental analyses of 2H5-alpha-linolenic acid and C-U-eicosapentaenoic acid toward synthesis of plasma labeled 22:6n-3 in newborn term infants.
    Lin YH; Llanos A; Mena P; Uauy R; Salem N; Pawlosky RJ
    Am J Clin Nutr; 2010 Aug; 92(2):284-93. PubMed ID: 20534748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega-3 fatty acid supplements and risk of atrial fibrillation and 'micro-atrial fibrillation': A secondary analysis from the OMEMI trial.
    Myhre PL; Berge T; Kalstad AA; Tveit SH; Laake K; Schmidt EB; Solheim S; Arnesen H; Seljeflot I; Tveit A
    Clin Nutr; 2023 Sep; 42(9):1657-1660. PubMed ID: 37515843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fish, fish-derived n-3 fatty acids, and risk of incident atrial fibrillation in the Atherosclerosis Risk in Communities (ARIC) study.
    Gronroos NN; Chamberlain AM; Folsom AR; Soliman EZ; Agarwal SK; Nettleton JA; Alonso A
    PLoS One; 2012; 7(5):e36686. PubMed ID: 22570739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between n-3 polyunsaturated fatty acids in erythrocytes and metabolic syndrome in Chinese men and women.
    Dai XW; Chen YM; Zeng FF; Sun LL; Chen CG; Su YX
    Eur J Nutr; 2016 Apr; 55(3):981-9. PubMed ID: 25935580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of omega-3 polyunsaturated fatty acids on cardiac rhythm: a critical reassessment.
    Billman GE
    Pharmacol Ther; 2013 Oct; 140(1):53-80. PubMed ID: 23735203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the association between whole blood Omega-3 Index, DHA, EPA, DHA, AA and n-6 DPA, and depression and self-esteem in adolescents of lower general secondary education.
    van der Wurff ISM; von Schacky C; Bergeland T; Leontjevas R; Zeegers MP; Kirschner PA; de Groot RHM
    Eur J Nutr; 2019 Jun; 58(4):1429-1439. PubMed ID: 29549496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. n-3 Docosapentaenoic Acid Intake and Relationship with Plasma Long-Chain n-3 Fatty Acid Concentrations in the United States: NHANES 2003-2014.
    Richter CK; Bisselou KS; Nordgren TM; Smith L; Appiah AK; Hein N; Anderson-Berry A; Kris-Etherton P; Hanson C; Skulas-Ray AC
    Lipids; 2019 Apr; 54(4):221-230. PubMed ID: 31025717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of plasma phospholipid long-chain ω-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study.
    Wu JH; Lemaitre RN; King IB; Song X; Sacks FM; Rimm EB; Heckbert SR; Siscovick DS; Mozaffarian D
    Circulation; 2012 Mar; 125(9):1084-93. PubMed ID: 22282329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eicosapentaenoic acid (EPA) has optimal chain length and degree of unsaturation to inhibit oxidation of small dense LDL and membrane cholesterol domains as compared to related fatty acids in vitro.
    Sherratt SCR; Juliano RA; Mason RP
    Biochim Biophys Acta Biomembr; 2020 Jul; 1862(7):183254. PubMed ID: 32135144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.